An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene

被引:39
作者
Ristow, M
Giannakidou, E
Hebinck, J
Busch, K
Vorgerd, M
Kotzka, J
Knebel, B
Mueller-Berghaus, J
Epplen, C
Pfeiffer, A
Kahn, CR
Doria, A
Krone, W
Mueller-Wieland, D
机构
[1] Joslin Diabet Ctr, Div Res, Sect Cellular & Mol Physiol, Boston, MA 02215 USA
[2] Joslin Diabet Ctr, Div Res, Sect Genet & Epidemiol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] Ruhr Univ Bochum, D-4630 Bochum, Germany
[5] Med Klin & Poliklin, Bergmannsheil, Germany
[6] Neurol Klin, Bergmannsheil, Germany
[7] Univ Cologne, Klin & Poliklin Innere Med 2, Cologne, Germany
[8] Univ Cologne, Kinderklin, Cologne, Germany
关键词
D O I
10.2337/diabetes.47.5.851
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Friedreich's ataxia is the most common hereditary ataxia and is frequently associated with disturbances of glucose metabolism. This autosomal recessive disease is caused by the decreased expression of a mitochondrial protein, frataxin, encoded by the X25 gene. Homozygous expansion of a GAA repeat in the first intron of X25 inhibits frataxin expression and is associated with clinical disease. we evaluated whether heterozygous expansions of the triplet repeat in the frataxin gene X25 may be associated with NIDDM in two genetically distinct populations-one in Germany (n = 358) and the other in the U.S. (n = 292)-using a polymerase chain reaction-based assay. Intermediate expansions (10-36 repeats), which are longer than normal but not sufficient for the appearance of the ataxia phenotype, were found in 24.7 and 27.3% of these two NIDDM cohorts compared with 7.6 and 6.3% of the matched control subjects (both P < 0.001), The odds ratios were 3.36 (95% CI 1.72-6.55) for the German group and 4.01 (2.08-7.74) for the U.S. group. Therefore, we conclude that the X25/frataxin GAA repeat polymorphism is associated with NIDDM in a frequency higher than any other mutation heretofore described. Further studies are needed to elucidate the possible role of frataxin in the pathogenesis of NIDDM.
引用
收藏
页码:851 / 854
页数:4
相关论文
共 19 条
[1]   Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin [J].
Babcock, M ;
deSilva, D ;
Oaks, R ;
DavisKaplan, S ;
Jiralerspong, S ;
Montermini, L ;
Pandolfo, M ;
Kaplan, J .
SCIENCE, 1997, 276 (5319) :1709-1712
[2]   Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion [J].
Campuzano, V ;
Montermini, L ;
Molto, MD ;
Pianese, L ;
Cossee, M ;
Cavalcanti, F ;
Monros, E ;
Rodius, F ;
Duclos, F ;
Monticelli, A ;
Zara, F ;
Canizares, J ;
Koutnikova, H ;
Bidichandani, SI ;
Gellera, C ;
Brice, A ;
Trouillas, P ;
DeMichele, G ;
Filla, A ;
DeFrutos, R ;
Palau, F ;
Patel, PI ;
DiDonato, S ;
Mandel, JL ;
Cocozza, S ;
Koenig, M ;
Pandolfo, M .
SCIENCE, 1996, 271 (5254) :1423-1427
[3]   Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes [J].
Campuzano, V ;
Montermini, L ;
Lutz, Y ;
Cova, L ;
Hindelang, C ;
Jiralerspong, S ;
Trottier, Y ;
Kish, SJ ;
Faucheux, B ;
Trouillas, P ;
Authier, FJ ;
Durr, A ;
Mandel, JL ;
Vescovi, A ;
Pandolfo, M ;
Koenig, M .
HUMAN MOLECULAR GENETICS, 1997, 6 (11) :1771-1780
[4]   Evolution of the Friedreich's ataxia trinucleotide repeat expansion: Founder effect and premutations [J].
Cossee, M ;
Schmitt, M ;
Campuzano, V ;
Reutenauer, L ;
Moutou, C ;
Mandel, JL ;
Koenig, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7452-7457
[5]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[6]   Differential stability of the (GAA)(n) tract in the Friedreich ataxia (STM7) gene [J].
Epplen, C ;
Epplen, JT ;
Frank, G ;
Miterski, B ;
Santos, EJM ;
Schols, L .
HUMAN GENETICS, 1997, 99 (06) :834-836
[7]  
Filla A, 1996, AM J HUM GENET, V59, P554
[8]   GLUCOSE-METABOLISM ALTERATIONS IN FRIEDREICHS ATAXIA [J].
FINOCCHIARO, G ;
BAIO, G ;
MICOSSI, P ;
POZZA, G ;
DIDONATO, S .
NEUROLOGY, 1988, 38 (08) :1292-1296
[9]  
HANAUER A, 1990, AM J HUM GENET, V46, P133
[10]  
Kahn CR, 1996, ANNU REV MED, V47, P509